Physician profile

Nathaniel Rosso Smilowitz

Cardiovascular Disease · New York, NY

NPI 1437475696

$44,030.44

in general payments reported to CMS, 2019-2025

11 companies · $18K in 2025

The $18K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

See the full distribution for Cardiovascular Disease

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$26,750.00
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program$1,875.00
Food and Beverage$1,528.16
Travel and Lodging$1,156.59

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $40,610.31 2019-2025 Optis, Coroflow, Pressurewire
Boston Scientific Corporation $2,393.78 2022-2025 General - Therapies, Stingray, Avvigo Guidance System
Shockwave Medical, INC $265.36 2022
Edwards Lifesciences Corporation $214.52 2022-2023 Sapien 3 Ultra Resilia
Abiomed $167.32 2021
Cathworks, INC. $129.58 2023 Ffrangio
Philips North America LLC $119.05 2025 Igt Devices Undivided
Medtronic, INC. $78.15 2022-2025 Symplicity G3
Inari Medical, INC. $29.47 2024 Flowtriever Catheter, S, Ct Thrombectomy System Kit
Terumo Medical Corporation $16.77 2023 Glidewire, Heartrail
Penumbra, INC. $6.13 2022

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Nathaniel Rosso Smilowitz

$44,030.44

in general payments reported 2019-2025

Years
2019-2025
Top company
Abbott Laboratories
Context
The $18K reported for 2025 was more than what 96% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).

https://glasscript.com/doctor/1087439/nathaniel-rosso-smilowitz

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.